Nancy E. Byerly

FDA investigator

Appears on 7 documents from 2015 to 2017, most often at sites in Washington. Most often cites design and construction features (21 CFR 211.42).

7
Documents on file
6.3
Observations per 483
2015
First seen
2017
Most recent

What they cite most

From 50 observations

Activity by year

2015: 1, 2016: 5, 2017: 1

Where

Washington 3 · Idaho 2 · Oregon 2

Is Nancy E. Byerly coming to your site?

Our team writes custom reports before an inspection: what this investigator cites most, how they write it up, and how your site's history compares, in one brief you can circulate.

Ask about any investigator in Claude or ChatGPT with the AI connector.

Inspection history

7 documents, newest first
FirmOpen
483 Puget SoWid Drug Corporation dba Key. Compounding PhannacyMar 8, 2017 · Federal Way, Washington
483 Ladd Family Pharmacy LLCSep 23, 2016 · Boise, Idaho
483 Trone Health Services, Inc.Jul 15, 2016 · Meridian, Idaho
483 Gabriel Cosmetics IncJun 16, 2016 · Redmond, Washington
483 Rain Shadow LabsMar 22, 2016 · Saint Helens, Oregon
483 Making Cosmetics, IncJan 15, 2016 · Snoqualmie, Washington
483 Kirkman Group, IncJul 15, 2015 · Lake Oswego, Oregon

About this profile

What does Nancy E. Byerly inspect?

Nancy E. Byerly appears on 7 documents on file covering 7 sites, most often in Washington.

What do they cite most often?

21 CFR 211.42 (design and construction features), followed by 21 CFR 211.113 and 21 CFR 211.22.

Can I read the observations?

Each document page previews the opening words of every observation. The full documents are available to buy, one at a time or together.

How current is this profile?

The most recent document on file for Nancy E. Byerly is dated Mar 8, 2017.

FDA Investigator Nancy E. Byerly: 483s & Inspections · FDA Intel